Vancomycin-Intermediate Staphylococcus aureus in Korea-Reference-Cited by-同舟云学术

Vancomycin-Intermediate Staphylococcus aureus in Korea

Published:2000-10 Issue:10 Volume:38 Page:3879-3881
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Kim Mi-Na¹,Pai Chik Hyun¹,Woo Jun Hee²,Ryu Ji So²,Hiramatsu Keiichi³

Affiliation:

1. Department of Clinical Pathology1 and

2. Department of Internal Medicine (Infectious Diseases),2 University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea, and

3. Department of Bacteriology, Juntendo University, Tokyo, Japan3

Abstract

ABSTRACT Recent reports on some methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin have been a major concern in Korea because of the widespread use of vancomycin due to a high prevalence of MRSA in the country. We describe a 45-year-old man with long-standing pelvic abscess due to MRSA. In spite of vancomycin and teicoplanin treatment for a long period of time, the patient died from MRSA sepsis. The blood culture isolate of MRSA exhibited reduced susceptibility to vancomycin (MIC, 8 μg/ml). This is the first report of a vancomycin-intermediate S. aureus case from Korea.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.38.10.3879-3881.2000

Reference13 articles.

1. Staphylococcus aureus with reduced susceptibility to vancomycin—United States;Centers for Disease Control and Prevention;Morb. Mortal. Wkly. Rep.,1997

2. Korean nationwide surveillance of antimicrobial resistance of bacteria in 1997;Chong Y.;Yonsei Med. J.,1998

3. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50

4. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility

5. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global distribution of heterogeneous vancomycin-intermediate Staphylococcus aureus strains (1997–2021): a systematic review and meta-analysis;Journal of Global Antimicrobial Resistance;2024-06

2. Model-informed precision dosing in vancomycin treatment;Frontiers in Pharmacology;2023-10-09

3. Decreased susceptibility to vancomycin and other mechanisms of resistance to antibiotics in Staphylococcus epidermidis as a therapeutic problem in hospital treatment;Scientific Reports;2023-08-21

4. A Case of Vancomycin-Induced Drug Reaction with Eosinophilia, Systemic Symptoms and Multiorgan Involvement Proven Using Lymphocyte Transformation Test;Annals of Dermatology;2023

5. Vancomycin heteroresistance among methicillin-resistant clinical isolates S. haemolyticus, S. hominis, S. simulans, and S. warneri;Brazilian Journal of Microbiology;2022-11-14